deferiprone has been researched along with Body Weight in 7 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present research is aimed to characterize the potential efficiency of two chelators after chromium(VI) administration for 60 days following two doses of 15 and 30 mg/kg chromium(VI) per body weight daily to male rats." | 3.79 | Chelation of chromium(VI) by combining deferasirox and deferiprone in rats. ( Dahooee Balooch, F; Ebrahimpour, R; Fatemi, SJ; Iranmanesh, M, 2013) |
| "Aluminum-induced maternal toxicity was evidenced by significant reductions in body weight gain, corrected body weight change, and food consumption." | 3.70 | Evaluation of the protective activity of deferiprone, an aluminum chelator, on aluminum-induced developmental toxicity in mice. ( Albina, ML; Bellés, M; Domingo, JL; Sanchez, DJ, 2000) |
| " According to the results of this study, uremia did not increase the toxic effects of L1." | 1.29 | Four-week oral toxicity study of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in uremic rats. ( Corbella, J; del Castillo, D; Domingo, JL; Gomez, M; Llobet, JM, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iranmanesh, M | 1 |
| Fatemi, SJ | 2 |
| Ebrahimpour, R | 1 |
| Dahooee Balooch, F | 1 |
| Tubafard, S | 1 |
| Wong, CS | 1 |
| Kwok, JC | 1 |
| Richardson, DR | 1 |
| Liu, P | 1 |
| Yao, YN | 1 |
| Wu, SD | 1 |
| Dong, HJ | 1 |
| Feng, GC | 1 |
| Yuan, XY | 1 |
| Gomez, M | 1 |
| Domingo, JL | 2 |
| del Castillo, D | 1 |
| Llobet, JM | 1 |
| Corbella, J | 1 |
| Wong, A | 1 |
| Alder, V | 1 |
| Robertson, D | 1 |
| Papadimitriou, J | 1 |
| Maserei, J | 1 |
| Berdoukas, V | 1 |
| Kontoghiorghes, G | 1 |
| Taylor, E | 1 |
| Baker, E | 1 |
| Albina, ML | 1 |
| Bellés, M | 1 |
| Sanchez, DJ | 1 |
7 other studies available for deferiprone and Body Weight
| Article | Year |
|---|---|
Chelation of chromium(VI) by combining deferasirox and deferiprone in rats.
Topics: Animals; Benzoates; Body Weight; Chelating Agents; Chelation Therapy; Chromium; Deferasirox; Deferip | 2013 |
Chelation of bismuth by combining desferrioxamine and deferiprone in rats.
Topics: Animals; Bismuth; Body Weight; Chelation Therapy; Deferiprone; Deferoxamine; Drug Therapy, Combinati | 2008 |
PCTH: a novel orally active chelator of the aroylhydrazone class that induces iron excretion from mice.
Topics: Administration, Oral; Animals; Blood Chemical Analysis; Body Weight; Cells, Cultured; Deferiprone; E | 2004 |
The efficacy of deferiprone on tissues aluminum removal and copper, zinc, manganese level in rabbits.
Topics: Aluminum; Animals; Body Weight; Copper; Deferiprone; Manganese; Pyridones; Rabbits; Spectrum Analysi | 2005 |
Four-week oral toxicity study of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in uremic rats.
Topics: Administration, Oral; Aluminum; Analysis of Variance; Animals; Blood Cells; Blood Chemical Analysis; | 1995 |
Liver iron depletion and toxicity of the iron chelator deferiprone (L1, CP20) in the guinea pig.
Topics: Administration, Oral; Animals; Auditory Threshold; Behavior, Animal; Blood Cell Count; Body Weight; | 1997 |
Evaluation of the protective activity of deferiprone, an aluminum chelator, on aluminum-induced developmental toxicity in mice.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Aluminum; Animals; Body Weight; Bone and Bones; D | 2000 |